Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice
Acta Biomaterialia · 2025
DOI: 10.1016/j.actbio.2025.07.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Hongji Zhou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Biological Science Research Center, Southwest University,…. Hauptthemen laut MEDLINE: Hydrogels, Colitis, Ulcerative, Adiponectin, Sericins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Chongqing Municipal Science and Technology Bureau, Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China.
Abstract (Originalsprache)
Ulcerative colitis (UC) is one type of inflammatory bowel diseases, and adiponectin (APN) is a potential therapeutic protein drug for treating UC. However, source and targeted delivery of APN to improve its effectiveness and bioavailability remain challenges. Here, we report a strategy to develop a sericin hydrogel (rhAPN-sh) through genetically engineering silkworm to spin silks mixed with recombinant human adiponectin (rhAPN), which efficiently overcome APN source and delivery. The rhAPN-sh exhibits desirable material performances such as stable internal crystal structure, fast swelling behavior, good biocompatibility, injectability. The rhAPN-sh effectively protected the APN through harsh gastroenteric environment for oral administration, which alleviated UC symptoms in mice with significant therapeutic effect by reconstructing colonic cell structure and colon length, reducing release of inflammatory factors, and maintaining stability of intestinal microbial population. These results indicate that the fabricated rhAPN-sh is a promising system for colitis treatment. STATEMENT OF SIGNIFICANCE: The present study presents an efficient strategy to treat ulcerative colitis (UC) by developing a genetically engineered sericin hydrogel delivering recombinant human adiponectin (rhAPN). Using transgenic silkworms, the system enables efficient rhAPN production, while the sericin hydrogel protects APN from gastrointestinal degradation, ensuring effective oral delivery. The sericin hydrogel alleviates UC symptoms in mice by reducing inflammation, restoring colon structure, and maintaining gut microbiota stability. This approach overcomes key challenges in APN protein drug delivery, offering a scalable, biocompatible, and effective therapeutic platform for UC and potentially other inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Biological Science Research Center, Southwest University, Chongqing 400715, PR China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, Department of Radiology, West China Second University Hospital, Sichuan University, 20# South Renmin Road, Chengdu, Si…
- Integrative Science Center of Germplasm Creation in Western China (CHONGQING) Science City, Biological Science Research Center, Southwest University, Chongqing 400715, PR China. Electronic address: wangf1986@swu.edu.cn.
Förderung
- Chongqing Municipal Science and Technology Bureau
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
- Key Technologies Research and Development Program
Zitieren
APA
Zhou, H., Zhou, Y., Deng, H., Chen, S., Meng, Z., He, M., Tu, D., Wang, H., Li, X., Wang, F., Lei, H., Yang, S., Dong, H., Xia, Q., Li, X., & Wang, F. (2025). Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.07.030
Vancouver
Zhou H, Zhou Y, Deng H, Chen S, Meng Z, He M, et al. Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.07.030
BibTeX
@article{Zhou2025,
author = {Zhou, Hongji and Zhou, Yujuan and Deng, Hanxin and Chen, Siyu and Meng, Zihan and He, Mengyao and Tu, Ding and Wang, He and Li, Xian and Wang, Fangyu and Lei, Hexu and Yang, Shifeng and Dong, Huan and Xia, Qingyou and Li, Xueming and Wang, Feng},
title = {Genetically engineered sericin hydrogels for the delivery of human adiponectin in treating ulcerative colitis in mice},
journal = {Acta Biomaterialia},
year = {2025},
doi = {10.1016/j.actbio.2025.07.030}
}
EUVIMED